InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,393.19
(
0.48%
)
Post# of 20617
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

gi197845

Send PM Follow Ignore
Followers 5
Posts 2466
Boards Moderated 0
Alias Born 08/16/2016

gi197845

Re: None

Tuesday, 12/06/2016 2:46:52 PM

Tuesday, December 06, 2016 2:46:52 PM

Post# of 20617
If Fluticare is rejected, it will be interesting for INNV to try and get its' stock back from Novalere.

Let's say Fluticare is approved in Q1 2017 and in general, INNV is doign well, who if anyone would be interested in buying INNV? (I doubt big pharma, because INNV really isn't pharma...) Would herbal life care about buying INNV?

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up